Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2...

Area of Science:

• Molecular Biology
• Transcription Factor Regulation
• Developmental Biology

Background:

• Core-binding factor alpha2 (CBFalpha2), also known as AML1 or PEBP2alphaB, is a key DNA-binding subunit of core-binding factors (CBFs).
• CBFs are heterodimeric transcription factors essential for mammalian development, including hematopoiesis and bone formation.
• CBFalpha2's Runt domain mediates DNA binding and heterodimerization with the CBFbeta subunit.

Purpose of the Study:

• To quantify and compare the cooperative DNA binding of CBFalpha2 with its partners CBFbeta and Ets-1.
• To identify auto-inhibitory sequences within CBFalpha2 and regulatory sequences influencing its interactions.
• To elucidate the mechanisms of positive and negative regulation governing CBFalpha2's DNA-binding activity.

Main Methods:

• Quantification of protein-protein interactions and DNA binding affinities.
• Identification of regulatory sequences through deletion analysis.
• Comparative analysis of cooperative DNA binding under different partnership conditions.

Main Results:

• CBFalpha2 contains auto-inhibitory sequences within its Runt domain and C-terminal regions (after amino acid 214).
• CBFbeta significantly enhances CBFalpha2 DNA binding (approx. 40-fold) by relieving intramolecular inhibition.
• Ets-1 stimulates CBFalpha2 DNA binding (7- to 10-fold), with specific N-terminal and internal sequences required for this cooperation.

Conclusions:

• CBFalpha2 activity is tightly regulated by intramolecular negative feedback and positive allosteric modulation by CBFbeta and Ets-1.
• CBFbeta and Ets-1 act as alternative partners, differentially regulating CBFalpha2's DNA binding and heterodimerization.
• Understanding these regulatory partnerships provides insights into the precise control of gene expression during mammalian development.